HIV

This information sheet discusses the impact of HIV/AIDS on communities of color. It reports that people of color have been disproportionately affected by HIV/AIDS and represent the highest number of new AIDS cases and the largest number of people living with AIDS in the US. The information sheet discusses the reasons behind these statistics and some of the programs that have been developed in response.

This report presents recommendations for preventing and controlling infectious diseases and managing personnel health and safety concerns and infection control in dental care settings. The report updates and revises previous CDC recommendations and incorporates infection-control measures.

This report focuses on the HIV/AIDS epidemic in the US and the work of the CDC’s division of HIV/AIDS prevention. It provides a brief history of the accomplishments since 1981, discusses the current status of the epidemic in the US and how CDC is responding, using surveillance data reported to CDC from the 25 states with long-standing HIV reporting. It looks back on the successes of HIV/AIDS prevention and presents future plans.

This pamphlet discusses HIV testing for newborn infants. It explains that the state of New York requires all babies to be tested. The pamphlet also explains when the mother will receive the results of the test, how a baby can get HIV, the meaning of a positive test for a baby, what happens for a mother who has HIV, and for a baby who has HIV. The pamphlet emphasizes that the results of the baby’s HIV test are confidential and that doctors can only share that information with others who are providing health care.

This report describes the HIV epidemic in Puerto Rico in 2006. The Puerto Rico Department of Health and Centers for Disease Control and Prevention (CDC) analyzed data on diagnoses of HIV infection, including infections that occurred in 2006 and in previous years, and used a stratified extrapolation approach developed by CDC to generate HIV incidence estimates. Results indicate that in 2006, an estimated 1,440 individuals aged 13 years or older were newly infected with HIV.

This report presents data for 2002-2007 on sexual and reproductive health of persons aged 10-24 years in the United States. Data were compiled from the National Vital Statistics System and multiple surveys and surveillance systems that monitor sexual and reproductive health outcomes. The report addresses three primary topics: (1) current levels of risk behavior and health outcomes; (2) disparities by sex, age, race/ethnicity, and geographic residence; and (3) trends over time.

This report describes the most recent trends in diagnoses of perinatal HIV infection by race/ethnicity, by summarizing results of analyses of national surveillance data from 34 states from 2004-2007. During 2004-2007, 85 percent of diagnoses of perinatal HIV were in blacks or African Americans (69 percent) or Hispanics or Latinos (16 percent). The average annual rate of diagnoses of perinatal HIV during that time was 12.3 per 100,000 among blacks, 2.1 per 100,000 among Hispanics, and 0.5 per 100,000 among whites.

This report describes HIV testing by the Rhode Island Department of Corrections (RIDOC) to assess HIV case identification, characterize HIV risk factors, and estimate the proportion of detainees who might not have been tested if testing had been delayed. Since 1991, RIDOC has offered testing routinely to every person admitted as part of the initial medical evaluation conducted within 24 hours of jail admission. Records of HIV testing of detainees during 2000-2007 were reviewed. About 102,229 tests were administered, and 169 detainees were diagnosed.

The Federal Bureau of Prisons (BOP) Stepwise Approach for Detecting, Evaluating, and Treating Chronic Hepatitis B Virus Infection provides recommendations for the medical management of federal inmates with chronic hepatitis B, or who are otherwise at risk of infection. The treatment of chronic hepatitis B in pregnancy or with hepatocellular carcinoma is beyond the scope of this guideline. For a more in-depth discussion of vaccination strategies and management of blood and body fluid exposures, the reader should refer to the BOP Clinical Practice Guidelines for those topics.